| dc.contributor.author | Bozkurt, Erhan | |
| dc.contributor.author | Beysel, Selvihan | |
| dc.contributor.author | Vurmaz, Ayhan | |
| dc.contributor.author | Atay, Emre | |
| dc.contributor.author | Gökaslan, Serkan | |
| dc.contributor.author | Ertekin, Ayşe | |
| dc.date.accessioned | 2025-12-28T16:54:02Z | |
| dc.date.available | 2025-12-28T16:54:02Z | |
| dc.date.issued | 2021 | |
| dc.identifier.issn | 2636-7688 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/464078 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12933/3296 | |
| dc.description.abstract | Aim: In this study, we aimed to investigate the relationship among cardiovascular risk factors (CRFs), atherogenic index of plasma(AIP) and high-sensitivity C-reactive protein (hs-CRP) levels in polycystic ovary syndrome (PCOS) patients and identify risks earlier.Materials and Methods: 131 patients diagnosed with PCOS according to Rotterdam criteria and 140 healthy controls were includedfrom August 2019 to October 2019. Blood samples were done in the early follicular phase of the patients and were done after 10-12hours of fasting. Results: AIP and hs-CRP levels were higher in PCOS group (p<0.001, p<0.001, respectively). In PCOS group significantly positivecorrelation was determined between CRFs and AIP. Significantly positive correlation was determined only between hs-CRP andtriglyceride levels (r=0.280, p<0.05). In PCOS group, there was a significantly positive correlation between hs-CRP levels and AIP(r=0.372, p<0.001). Conclusion: AIP and hs-CRP may be beneficial markers for early monitoring of cardiovascular diseases in PCOS patients. | |
| dc.language.iso | en | |
| dc.relation.ispartof | Annals of Medical Research | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Tıbbi Araştırmalar Deneysel | |
| dc.subject | Kadın Hastalıkları ve Doğum | |
| dc.subject | Kalp ve Kalp Damar Sistemi | |
| dc.title | Evaluation of relationship among polycystic ovarysyndrome, atherogenic index of plasma, and highsensitive C reactive protein | |
| dc.type | Article | |
| dc.department | Afyonkarahisar Sağlık Bilimleri Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Afyonkarahisar, Türkiye,Afyonkarahisar Sağlık Bilimleri Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Endokrinoloji ve Metabolizma Anabilim Dalı, Afyonkarahisar, Türkiye,Afyonkarahisar Sağlık Bilimleri Üniversitesi, Tıp Fakültesi, Tıbbi Biyokimya Anabilim Dalı, Afyonkarahisar, Türkiye,Afyonkarahisar Sağlık Bilimleri Üniversitesi, Tıp Fakültesi, Anatomi Anabilim Dalı, Afyonkarahisar, Türkiye,Afyonkarahisar Sağlık Bilimleri Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Afyonkarahisar, Türkiye,Afyonkarahisar Sağlık Bilimleri Üniversitesi, Tıp Fakültesi, Acil Tıp Anabilim Dalı, Afyonkarahisar, Türkiye | |
| dc.identifier.volume | 28 | |
| dc.identifier.issue | 3 | |
| dc.identifier.startpage | 564 | |
| dc.identifier.endpage | 570 | |
| dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.department-temp | Afyonkarahisar Sağlık Bilimleri Üniversitesi | |
| dc.identifier.trdizinid | 464078 | |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.snmz | KA_TR-Dizin_20251227 | |